150 related articles for article (PubMed ID: 36367044)
21. Expression of signal transducer and activator of transcription 3 (STAT3) in primary central nervous system diffuse large B-cell lymphoma: a retrospective analysis of 17 cases.
Vajpayee N; Hussain J; Tolocica I; Hutchison RE; Gajra A
J Neurooncol; 2010 Nov; 100(2):249-53. PubMed ID: 20446017
[TBL] [Abstract][Full Text] [Related]
22. Primary central nervous system lymphoma: time for diagnostic biomarkers and biotherapies?
Royer-Perron L; Hoang-Xuan K; Alentorn A
Curr Opin Neurol; 2017 Dec; 30(6):669-676. PubMed ID: 28922238
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.
Lin CH; Kuo KT; Chuang SS; Kuo SH; Chang JH; Chang KC; Hsu HC; Tien HF; Cheng AL
Clin Cancer Res; 2006 Feb; 12(4):1152-6. PubMed ID: 16489068
[TBL] [Abstract][Full Text] [Related]
24. Primary central nervous system lymphoma: status and advances in diagnosis, molecular pathogenesis, and treatment.
Zhang Y; Zhou DB
Chin Med J (Engl); 2020 Jun; 133(12):1462-1469. PubMed ID: 32452898
[TBL] [Abstract][Full Text] [Related]
25. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
[TBL] [Abstract][Full Text] [Related]
26. Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
Fischer L; Hummel M; Korfel A; Lenze D; Joehrens K; Thiel E
Neuro Oncol; 2011 Oct; 13(10):1090-8. PubMed ID: 21803762
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in primary central nervous system lymphoma.
Morales-Martinez A; Nichelli L; Hernandez-Verdin I; Houillier C; Alentorn A; Hoang-Xuan K
Curr Opin Oncol; 2022 Nov; 34(6):676-684. PubMed ID: 36093869
[TBL] [Abstract][Full Text] [Related]
28. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
Yuan J; Gu K; He J; Sharma S
Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
[TBL] [Abstract][Full Text] [Related]
29. Primary central nervous system lymphoma.
Schaff LR; Grommes C
Blood; 2022 Sep; 140(9):971-979. PubMed ID: 34699590
[TBL] [Abstract][Full Text] [Related]
30. Testicular Relapse of Primary Diffuse Large B-cell Lymphoma of the Central Nervous System - a Rare Occurrence.
Ollila TA; Kishkovich TP; Olszewski AJ; Patel NR; Jackson C; Roussel B; Niroula R; Treaba DO
R I Med J (2013); 2023 Mar; 106(2):8-12. PubMed ID: 36848533
[TBL] [Abstract][Full Text] [Related]
31. A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study.
Labreche K; Daniau M; Sud A; Law PJ; Royer-Perron L; Holroyd A; Broderick P; Went M; Benazra M; Ahle G; Soubeyran P; Taillandier L; Chinot OL; Casasnovas O; Bay JO; Jardin F; Oberic L; Fabbro M; Damaj G; Brion A; Mokhtari K; Philippe C; Sanson M; Houillier C; Soussain C; Hoang-Xuan K; Houlston RS; Alentorn A;
Neuro Oncol; 2019 Aug; 21(8):1039-1048. PubMed ID: 31102405
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?
Kim JA; Kim SJ; Do IG; Jin J; Nam DH; Ko YH; Kim K; Kim WS
Leuk Lymphoma; 2011 Feb; 52(2):205-13. PubMed ID: 21281236
[TBL] [Abstract][Full Text] [Related]
33. CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma.
Yamaguchi J; Ohka F; Lushun C; Motomura K; Aoki K; Takeuchi K; Nagata Y; Ito S; Mizutani N; Ohno M; Suzaki N; Takasu S; Seki Y; Kano T; Wakabayashi K; Oyama H; Kurahashi S; Tanahashi K; Hirano M; Shimizu H; Kitano Y; Maeda S; Yamazaki S; Wakabayashi T; Kondo Y; Natsume A; Saito R
Cancer Med; 2023 Mar; 12(6):7116-7126. PubMed ID: 36478416
[TBL] [Abstract][Full Text] [Related]
34. Primary central nervous system lymphoma: Novel precision therapies.
Mondello P; Mian M; Bertoni F
Crit Rev Oncol Hematol; 2019 Sep; 141():139-145. PubMed ID: 31295667
[TBL] [Abstract][Full Text] [Related]
35. Pathway analysis of primary central nervous system lymphoma.
Tun HW; Personett D; Baskerville KA; Menke DM; Jaeckle KA; Kreinest P; Edenfield B; Zubair AC; O'Neill BP; Lai WR; Park PJ; McKinney M
Blood; 2008 Mar; 111(6):3200-10. PubMed ID: 18184868
[TBL] [Abstract][Full Text] [Related]
36. Primary treatment and recent survival trends in patients with primary diffuse large B-cell lymphoma of central nervous system, 1995-2016: A population-based SEER analysis.
Chen C; Sun P; Sun XQ; Chen SY; Hang Yang ; Wang Y; Li ZM
Hematol Oncol; 2023 Apr; 41(2):248-256. PubMed ID: 34472655
[TBL] [Abstract][Full Text] [Related]
37. Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.
Lemma SA; Kuusisto M; Haapasaari KM; Sormunen R; Lehtinen T; Klaavuniemi T; Eray M; Jantunen E; Soini Y; Vasala K; Böhm J; Salokorpi N; Koivunen P; Karihtala P; Vuoristo J; Turpeenniemi-Hujanen T; Kuittinen O
Carcinogenesis; 2017 Aug; 38(8):812-820. PubMed ID: 28854563
[TBL] [Abstract][Full Text] [Related]
38. Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
Sun X; Wang C; Chen C; Huang J; Wu X; Wang Y; He X; Cao J; Jiang W; Sun P; Li Z
Hematol Oncol; 2021 Dec; 39(5):625-638. PubMed ID: 34543472
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.
Ferreri AJ; Dell'Oro S; Capello D; Ponzoni M; Iuzzolino P; Rossi D; Pasini F; Ambrosetti A; Orvieto E; Ferrarese F; Arrigoni G; Foppoli M; Reni M; Gaidano G
Br J Haematol; 2004 Sep; 126(5):657-64. PubMed ID: 15327516
[TBL] [Abstract][Full Text] [Related]
40. New genetic prognostic biomarkers in primary central nervous system lymphoma (PCNSL).
Gomes Candido Reis D; Levy D; Lage LAPC; Culler HF; Rocha V; Bydlowski SP; Nogueira Zerbini MC; Pereira J
Brain Behav; 2021 Apr; 11(4):e02061. PubMed ID: 33591648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]